Abstract: The present invention relates to improved treatment of diseases and disorders of the central nervous system by administration of apomorphine. In particular, the administration is via pulmonary inhalation. The invention provides the means for improving the treatment of a number of conditions, including Parkinson's Disease.
Type:
Application
Filed:
October 31, 2008
Publication date:
November 18, 2010
Applicant:
VECTURAL LIMITED
Inventors:
David Ganderton, Mark Jonathan Main, Frazer Giles Morgan